Search

everythinglearnresearchcommunity

for

Search:↓

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

The document concluded that certain clinical signs and hair growth tests help diagnose Short Anagen Syndrome.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

GT20029 showed some hair growth improvement, but longer studies are needed for better results.

Topical treatment SM04554 safely promotes hair growth in male baldness.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Long COVID recovery is hindered by smoking, with hair loss being a difficult symptom to treat.

Higher fluence in hair removal damages hair follicles more, while lower fluence mimics natural hair regression, with long-term IPL treatments effectively reducing hair.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Hair miniaturization is the main cause of long-term hair loss after stem cell transplantation and chemotherapy, and treatments like topical minoxidil can help improve hair volume.

Post-COVID-19 hair loss is different from androgenetic alopecia and can be identified by lower copper and higher selenium levels.

Mimicking growth factors in a topical solution can prolong hair growth phase and reduce hair loss without side effects.

India is ideal for dermatology trials due to diverse patients and cost-effectiveness.

Apoptosis may play a role in feather and hair development, SF-36 is better for mental health in skin patients, a psoriasis gene is found in Caucasians, eosinophils might not be crucial for some skin allergies, and changes in atopic dermatitis could increase skin sensitivity.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

Phage therapy could be a safe and effective new treatment for acne.

Cynatine HNS improves hair and nail quality in 90 days.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

Phage-containing hydrogels effectively heal wounds infected with Enterococcus faecalis.

Niosomal methylene blue gel effectively improves moderate to severe acne.

Vegan exosome-like vesicles from microalgae improve skin and hair health, reducing wrinkles and enhancing elasticity.

Sublingual minoxidil safely increases hair growth in transgender people on testosterone therapy.

The trial aims to test a new treatment for hair loss in young men using stem cell-derived vesicles.

PRP injections with tadalafil and stretching safely improved Peyronie's symptoms but didn't significantly change curvature long-term.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.